[Skip to Content]
[Skip to Content Landing]
April 27, 1957


JAMA. 1957;163(17):1623. doi:10.1001/jama.1957.02970520057016

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


On page 28 of the advertising section of this issue of The Journal there appears a reduced reproduction of the Federal Food and Drug Administration's public warning of the dangers involved in patronizing the Hoxsey cancer treatment. Readers of The Journal may wish to remove the page and post it conspicuously in their offices. The government warning has been distributed to post offices and other federal buildings for posting.

This unusual activity on the part of an agency of the federal government is necessitated by reason of a concentrated campaign by Mr. Hoxsey and others who not only claim merit for the treatment but are petitioning Congress, through those who are in sympathy with them, to investigate the Federal Food and Drug Administration's efforts to stop Hoxsey's misrepresentations.

In April, 1956, the Food and Drug Administration issued a warning and thereby notified the public that the Hoxsey treatment was not

First Page Preview View Large
First page PDF preview
First page PDF preview